{
  "main_header": {
    "sid": 487832,
    "name": "Kobo Biotech",
    "stock_name": "Kobo Biotech",
    "full_name": "Kobo Biotech Ltd",
    "name_url": "stocks-analysis/kobo-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "3.00",
    "chg": 0.12,
    "chgp": "4.17%",
    "dir": 1,
    "prev_price": "2.88",
    "mcapval": "7.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531541,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE881A01015",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "10.71 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/kobo-biotech-487832-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kobo Biotech Faces Intense Selling Pressure Amid Consecutive Losses and Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kobo-biotech-faces-severe-selling-pressure-as-stock-hits-lower-circuit-3746493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KoboBiotech_only_sellers_3746493.png",
        "date": "2025-12-04 10:35:47",
        "description": "Kobo Biotech Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.94% today and showing no buying interest. The commodity chemicals company continues to underperform the broader market, reflecting distress selling signals and a challenging trading environment."
      },
      {
        "title": "Why is Kobo Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kobo-biotech-fallingrising-3744993",
        "imagepath": "",
        "date": "2025-12-04 00:50:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Extended Underperformance Against Market Benchmarks</strong></p>\n<p>Kobo Biotech’s recent price action is part of a longer-term pattern of underperformance relative to the broader market. Over the past month, the stock has declined by 28.74%, while the Sensex has gained 1.34%. This divergence is even more pronounced over the one-year and three-year horizons, with the stock falling 15.33% and 53.36% respectively, compared to Sensex gains of 5.27% and 35.37%. Over five years, the stock has lost 63.46% of its value, whereas the Sensex has nearly doubled, rising 90.68%. These figures underscore a persistent weakness in Kobo Biotech’s share price relative to the benchmark index, signalling structural challenges or lack of investor confidence in the company’s prospects.</p>\n<p><strong>Technical In..."
      }
    ],
    "total": 174,
    "sid": "487832",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/kobo-biotech-487832"
  },
  "announcements": [
    {
      "caption": "Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors",
      "datetime": "30-Oct-2025",
      "details": "Outcome of the 7th CoC Meeting held on 06-05-2025",
      "source": "BSE"
    },
    {
      "caption": "Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors",
      "datetime": "30-Oct-2025",
      "details": "The 15th Meeting of Committee of Creditors of Kobo Biotech Limited was held on Wednesday1st October2025 at 03:45 p.m. at 215 Laxmi Plaza Laxmi Industrial Estate New Link Road Andheri West Mumbai 400053 through video conferencing.",
      "source": "BSE"
    },
    {
      "caption": "Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors",
      "datetime": "30-Oct-2025",
      "details": "Outcome of the 4th CoC Meeting held on 13-01-2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kobo Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 21 Sep 12",
          "dt": "2012-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kobo Biotech Faces Intense Selling Pressure Amid Consecutive Losses and Market Underperformance

2025-12-04 10:35:47

Kobo Biotech Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.94% today and showing no buying interest. The commodity chemicals company continues to underperform the broader market, reflecting distress selling signals and a challenging trading environment.

Read More

Why is Kobo Biotech falling/rising?

2025-12-04 00:50:02

Extended Underperformance Against Market Benchmarks Kobo Biotech’s recent price action is part of a longer-term pattern of underperformance relative to the broader market. Over the past month, the stock has declined by 28.74%, while the Sensex has gained 1.34%. This divergence is even more pronounced over the one-year and three-year horizons, with the stock falling 15.33% and 53.36% respectively, compared to Sensex gains of 5.27% and 35.37%. Over five years, the stock has lost 63.46% of its value, whereas the Sensex has nearly doubled, rising 90.68%. These figures underscore a persistent weakness in Kobo Biotech’s share price relative to the benchmark index, signalling structural challenges or lack of investor confidence in the company’s prospects. Technical In...

Read More

View All News